Jeroen Methorst

Jeroen Methorst

Auto-generated profile, based on publicly available information

Jeroen Methorst

Department of physics Technical University Dortmund Dortmund Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in Journal of Chemical Theory and Computation
Verified
Journal Article
Open access
JMJeroen Methorst
Jeroen Methorst
NHNiek van Hilten
Niek van Hilten
AHArt Hoti
Art Hoti
KSKai Steffen Stroh
Kai Steffen Stroh
HRHerre Jelger Risselada
Herre Jelger Risselada
Biomolecular research traditionally revolves around comprehending the mechanisms through which peptides or proteins facilitate specific functions, often driven by their relevance to clinical ailments. This conventional approach assumes that unraveling mechanisms is a prerequisite for wielding control over functionality, which stands as the ultimate research goal. However, an alternative perspective emerges from physics-based inverse design, shifting the focus from mechanisms to the direct acquisition of functional control strategies. By embracing this methodology, we can uncover solutions that might not have direct parallels in natural systems, yet yield crucial insights into the isolated molecular elements dictating functionality. This provides a distinctive comprehension of the underlying mechanisms.In this context, we elucidate how physics-based inverse design, facilitated by evolutionary algorithms and coarse-grained molecular simulations, charts a promising course for innovating the reverse engineering of biopolymers interacting with intricate fluid phases such as lipid membranes and liquid protein phases. We introduce evolutionary molecular dynamics (Evo-MD) simulations, an approach that merges evolutionary algorithms with the Martini coarse-grained force field. This method directs the evolutionary process from random amino acid sequences toward peptides interacting with complex fluid phases such as biological lipid membranes, offering significant promises in the development of peptide-based sensors and drugs. This approach can be tailored to recognize or selectively target specific attributes such as membrane curvature, lipid composition, membrane phase (e.g., lipid rafts), and protein fluid phases. Although the resulting optimal solutions may not perfectly align with biological norms, physics-based inverse design excels at isolating relevant physicochemical principles and thermodynamic driving forces governing optimal biopolymer interaction within complex fluidic environments. In addition, we expound upon how physics-based evolution using the Evo-MD approach can be harnessed to extract the evolutionary optimization fingerprints of protein-lipid interactions from native proteins. Finally, we outline how such an approach is uniquely able to generate strategic training data for predictive neural network models that cover the whole relevant physicochemical domain. Exploring challenges, we address key considerations such as choosing a fitting fitness function to delineate the desired functionality. Additionally, we scrutinize assumptions tied to system setup, the targeted protein structure, and limitations posed by the utilized (coarse-grained) force fields and explore potential strategies for guiding evolution with limited experimental data. This discourse encapsulates the potential and remaining obstacles of physics-based inverse design, paving the way for an exciting frontier in biomolecular research.

20 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JMJeroen Methorst
Jeroen Methorst
NVNino Verwei
Nino Verwei
CHChristian Hoffmann
Christian Hoffmann
PCPaweł Chodnicki
Paweł Chodnicki
RSRoberto Sansevrino
Roberto Sansevrino
HRHerre Jelger Risselada
Herre Jelger Risselada
The existence of linear cholesterol-recognition motifs in transmembrane domains has long been debated. Evolutionary molecular dynamics (Evo-MD) simulations—genetic algorithms guided by (coarse-grained) molecular force-fields–reveal that thermodynamic optimal cholesterol attraction in isolated alpha-helical transmembrane domains occurs when multiple consecutive lysine/arginine residues flank a short hydrophobic segment. These findings are supported by atomistic simulations and solid-state NMR experiments. Our analyses illustrate that linear motifs in transmembrane domains exhibit weak binding affinity for cholesterol, characterized by sub-microsecond residence times, challenging the predictive value of linear CRAC/CARC motifs for cholesterol binding. Membrane protein database analyses suggest even weaker affinity for native linear motifs, whereas live cell assays demonstrate that optimizing cholesterol binding restricts transmembrane domains to the endoplasmic reticulum post-translationally. In summary, these findings contribute to our understanding of cholesterol-protein interactions and offer insight into the mechanisms of protein-mediated cholesterol regulation within membranes.

10 April 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
NHNiek van Hilten
Niek van Hilten
NVNino Verwei
Nino Verwei
JMJeroen Methorst
Jeroen Methorst
CNCarsten Nase
Carsten Nase
ABAndrius Bernatavicius
Andrius Bernatavicius
HRHerre Jelger Risselada
Herre Jelger Risselada
Motivation: Many membrane peripheral proteins have evolved to transiently interact with the surface of (curved) lipid bilayers. Currently, methods to quantitatively predict sensing and binding free energies for protein sequences or structures are lacking, and such tools could greatly benefit the discovery of membrane-interacting motifs, as well as their de novo design. Results: Here, we trained a transformer neural network model on molecular dynamics data for > 50,000 peptides that is able to accurately predict the (relative) membrane-binding free energy for any given amino acid sequence. Using this information, our physics-informed model is able to classify a peptide’s membrane-associative activity as either non-binding, curvature sensing, or membrane binding. Moreover, this method can be applied to detect membraneinteraction regions in a wide variety of proteins, with comparable predictive performance as state-of-the-art data-driven tools like DREAMM, PPM3, and MODA, but with a wider applicability regarding protein diversity, and the added feature to distinguish curvature sensing from general membrane binding. Availability: We made these tools available as a web server, coined Protein-Membrane Interaction predictor (PMIpred), which can be accessed at https://pmipred.fkt.physik.tu-dortmund.de .

9 January 2026 in Advanced Science
Verified
Journal Article
Open access
PMPascal von Maltitz
Pascal von Maltitz
NHNiek van Hilten
Niek van Hilten
TWTatjana Weil
Tatjana Weil
TTThunchanok Thummaraj
Thunchanok Thummaraj
JMJeroen Methorst
Jeroen Methorst
JMJan Münch
Jan Münch
Broad‐spectrum antivirals are urgently needed to counter emerging viral threats. Targeting the viral envelope, an essential, conserved, and host‐derived structure, offers a promising strategy with a low risk of resistance. Here, we report the in silico design and experimental characterization of P1.6, a 24‐mer peptide generated using an evolutionary molecular dynamics (Evo‐MD) platform and optimized to sense and exploit lipid packing defects in viral membranes. Among nine Evo‐MD–derived candidates, P1.6 showed the strongest membrane‐disruptive activity and inhibited HIV‐1, Zika virus, and herpes simplex viruses with IC 50 values ranging from ∼0.06 to 3.5 µ m . P1.6 efficiently disrupted virus‐like liposomes without causing cytotoxicity or hemolysis at antiviral concentrations. All‐atom MD simulations predicted a predominantly α‐helical solution structure with a central kink and flexible termini. Upon membrane engagement, this kink was largely lost, yielding a more continuous and stabilized helix. ATR‐FTIR spectroscopy confirmed the membrane‐induced increase in helicity. Coarse‐grained MD simulations further demonstrated that P1.6 stabilizes transient membrane pores, while electron microscopy of treated HIV‐1 particles revealed extensive envelope rupture and capsid release. Together, these results establish P1.6 as a potent membrane‐active antiviral lead and highlight the utility of Evo‐MD–guided peptide design to target conserved biophysical vulnerabilities in viral envelopes.